ArticleAntimicrobial agents and chemotherapy2003
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae.
Article in Antimicrobial agents and chemotherapy, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 77 citations in OpenAlex.
- Recent development and fighting strategies for lincosamide antibiotic resistance.Clinical microbiology reviews · 2024Review
- Granadaene Photobleaching Reduces the Virulence and Increases Antimicrobial Susceptibility of Streptococcus agalactiae.Photochemistry and photobiology · 2021Article
- New genetic context ofAntimicrobial resistance and infection control · 2019Article
- The draft genomes and investigation of serotype distribution, antimicrobial resistance of group B Streptococcus strains isolated from urine in Suzhou, China.Annals of clinical microbiology and antimicrobials · 2018Article
- ICEFrontiers in microbiology · 2017Article
- Streptococcus agalactiae from pregnant women: antibiotic and heavy-metal resistance mechanisms and molecular typing.Epidemiology and infection · 2016Article
- Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013.Journal of clinical microbiology · 2016Article
- Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015Article
- Article
- DNA microarray-based typing of Streptococcus agalactiae isolates.Journal of clinical microbiology · 2014Article
- Risk factors associated with group B streptococcus resistant to clindamycin and erythromycin in pregnant korean women.Infection & chemotherapy · 2013Article
- Phenotypic and genotypic characterization of Streptococcus agalactiae in pregnant women. First study in a province of Argentina.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2013Article
- Dominance of serotype Ia among group B Streptococci causing invasive infections in nonpregnant adults in Portugal.Journal of clinical microbiology · 2012Article
- Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria.Antimicrobial agents and chemotherapy · 2011Article
- Phenotypic and genotypic characterization of group B streptococcal isolates in southern Brazil.Journal of clinical microbiology · 2010Article
- Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2006Article
- Erythromycin resistance and genetic elements carrying macrolide efflux genes in Streptococcus agalactiae.Antimicrobial agents and chemotherapy · 2005Article
- Correlation of serotypes and genotypes of macrolide-resistant Streptococcus agalactiae.Yonsei medical journal · 2005Article
- New lnu(C) gene conferring resistance to lincomycin by nucleotidylation in Streptococcus agalactiae UCN36.Antimicrobial agents and chemotherapy · 2005Article
- Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain.Antimicrobial agents and chemotherapy · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rates of resistance to erythromycin and clindamycin among Streptococcus agalactiae strains isolated in our hospital increased from 4.2 and 0.8% in 1993 to 17.4 and 12.1%, respectively, in 2001. Erythromycin resistance was mainly due to the presence of an Erm(B) methylase, while the M phenotype was detected in 3.8% of the strains. Telithromycin was very active against erythromycin-resistant strains, irrespective of their mechanisms of macrolide resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.